Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

252
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
252
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

2.2K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.2K
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

30
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
30
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

1.2K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.2K
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

299
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
299
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Dual Anaplerotic Model (DAM): Integral Roles of Pyruvate Carboxylase and the GABA Shunt in Beta Cell Insulin Secretion.

Life (Basel, Switzerland)·2026
Same author

Optimizing Digital Image Quality for Improved Skin Cancer Detection.

Journal of imaging·2025
Same author

The Synergistic Impact of Glycolysis, Mitochondrial OxPhos, and PEP Cycling on ATP Production in Beta Cells.

International journal of molecular sciences·2025
Same author

The Association Between Periodontal Inflamed Surface Area (PISA), Inflammatory Biomarkers, and Mitochondrial DNA Copy Number.

Journal of clinical medicine·2025
Same author

Being Popular and Being Liked: Goals, Behaviors, and Norm Salience.

Journal of youth and adolescence·2024
Same author

Self-Organization of Enzyme-Catalyzed Reactions Studied by the Maximum Entropy Production Principle.

International journal of molecular sciences·2023

Related Experiment Video

Updated: Jun 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K

Cardiovascular Comorbidities in COVID-19: Comprehensive Analysis of Key Topics.

Rene Markovič1,2, Luka Ternar3, Tim Trstenjak3

  • 1Faculty of Natural Sciences and Mathematics, University of Maribor, Maribor, Slovenia.

Interactive Journal of Medical Research
|July 24, 2024
PubMed
Summary

This study highlights how cardiovascular diseases and metabolic disorders, including glucose and iron metabolism issues, are significantly linked to COVID-19 severity. Understanding these comorbidities is crucial for developing better healthcare strategies.

Keywords:
COVID-19MeSHcardiovascular diseaseseffectiveembolismembolism and thrombosisglucoseheart failurehyperglycemiahypertensioniron metabolism disordersmetabolic disordersnutritionalthrombosisvascular disease

More Related Videos

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Related Experiment Videos

Last Updated: Jun 19, 2025

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

7.6K
Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
13:07

Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression

Published on: January 15, 2022

3.9K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K

Area of Science:

  • Medical Informatics
  • Epidemiology
  • Public Health

Background:

  • The interplay between COVID-19 and cardiovascular diseases (CVDs) and metabolic disorders is a critical research area.
  • Understanding how comorbidities influence COVID-19 risk and severity is increasingly important.

Purpose of the Study:

  • To systematically analyze the association between COVID-19 and cardiovascular and metabolic disorders.
  • To examine the roles of specific CVDs (e.g., embolism, thrombosis, hypertension, heart failure) and metabolic disorders (e.g., glucose and iron metabolism) in COVID-19 comorbidity.

Main Methods:

  • Systematic literature search in PubMed (2000-2022) for COVID-19 and CVD-related articles.
  • Creation of two peer-reviewed databases for comparative analysis.
  • Statistical analysis of Medical Subject Headings (MeSH) term frequency and relevance to identify associations.

Main Results:

  • Cardiovascular Diseases and Nutritional and Metabolic Diseases were key Level 1 MeSH descriptors for COVID-19 comorbidities.
  • "Vascular Disease" and "Heart Disease" were prominent Level 2/3 descriptors under CVDs.
  • Glucose metabolism disorders were frequently linked to COVID-19 comorbidities like embolism and heart failure; iron deficiency showed distinct patterns.

Conclusions:

  • This research provides a foundation for knowledge-based approaches to understand COVID-19 comorbidities.
  • Findings can inform the development of targeted healthcare strategies and interventions for pandemic preparedness.